Poorly soluble compounds often demonstrate lower bioavailability, which can reduce the efficacy of the drug substance or product. Quadrant 2™ is a diagnostic tool for early development, which allows us to see in-silico predictions of formulations.
The results of this diagnostic tool can save time and costs by avoiding trial and error approaches because we can quickly provide a solution to enhance solubility:
Download this fact sheet to learn more about the Quadrant 2™ predictive platform.